A facile, branched DNA assay to quantitatively measure glucocorticoid receptor auto-regulation in T-cell acute lymphoblastic leukemia

Chinese Journal of Cancer

Volumn 31, Issue 8, 2012, Pages 381-391

  Schwartz, Jason R ^a   Sarvaiya, Purvaba J ^a   Leiva, Lily E ^a,b   Velez, Maria C ^a,b   Singleton, Tammuella C ^a,b   Yu, Lolie C ^a,b   Vedeckis, Wayne V ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Apoptosis; Branched DNA assay; Glucocorticoid receptor; T cell acute lymphoblastic leukemia

Indexed keywords

GLUCOCORTICOID RECEPTOR;

ACCURACY; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; AUTOREGULATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA PROBE; EXON; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; PREDICTION; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CELL LINE, TUMOR; CHILD; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; EXONS; GLUCOCORTICOIDS; HUMANS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84865219243     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.012.10044     Document Type: Article

References (35)

1. Langebrake C, Reinhardt D, Ritter J. Minimising the long-termadverse effects of childhood leukaemia therapy. Drug Saf,2002,25:1057-1077.
2. Pearson OH, Eliel LP, Rawson, RW, et al. Adrenocorticotropic hormone-and cortisone-in duced regression of lymphoid tumors in man: a preliminary report. Cancer, 1949,2:943-945.
3. Ploner C, Schmidt S, Presul E, et al. Glucocorticoid-inducedapoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J Steroid Biochem Mol Biol, 2005,93:153-160.
4. Kaspers GJ, Pieters R, Van Zantwijk CH, et al. Prednisoloneresistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood, 1998,92:259-266.
5. Hulleman E, Kazemier KM, Holleman A, et al. Inhibition ofglycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood, 2009,113:2014-2021.
6. Den Boer ML, Harms DO, Pieters R, et al. Patient stratificationbased on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol, 2003,21:3262-3268.
7. Dordelmann M, Reiter A, Borkhardt A, et al. Prednisoneresponse is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood, 1999,94:1209-1217.
8. Hochhauser CJ, Lewis M, Kamen BA, et al. Steroid-inducedalterations of mood and behavior in children during treatment for acute lymphoblastic leukemia. Support Care Cancer, 2005,13:967-974.
9. Schimmer BP, Parker KL. Adrenocorticotropic hormone;adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed. New York: McGraw-Hill, 2006:1587-1612.
10. de Vries MA, van Litsenburg RR, Huisman J, et al. Effect ofdexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study. Health Qual Life Outcomes, 2008,6:103.
11. Webster JC, Cidlowski JA. Mechanisms of glucocorticoid-receptor-mediated repression of gene expression. Trends Endocrinol Metab, 1999,10:396-402.
12. McKay LI, Cidlowski JA. CBP (CREB binding protein)integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol, 2000,14:1222-1234.
13. Schule R, Rangarajan P, Kliewer S, et al. Functionalantagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell, 1990,62:1217-1226.
14. Jonat C, Rahmsdorf HJ, Park KK, et al. Antitumor promotionand antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell, 1990,62:1189-1204.
15. Mullick J, Anandatheerthavarada HK, Amuthan G, et al. Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter. J Biol Chem, 2001,276:18007-18017.
16. Park SK, Beaven MA. Mechanism of upregulation of theinhibitory regulator, src-like adaptor protein (SLAP), by glucocorticoids in mast cells. Mol Immunol, 2009,46:492-497.
17. Geng CD, Vedeckis WV. Steroid-responsive sequences in thehuman glucocorticoid receptor gene 1A promoter. Mol Endocrinol, 2004,18:912-924.
18. Geng CD, Vedeckis WV. c-Myb and members of the c-Etsfamily of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J Biol Chem, 2005,280:43264-43271.
19. Geng CD, Schwartz JR, Vedeckis WV. A conserved molecularmechanism is responsible for the auto-up-regulation of glucocorticoid receptor gene promoters. Mol Endocrinol, 2008,22:2624-2642.
20. Pedersen KB, Vedeckis WV. Quantification and glucocorticoidregulation of glucocorticoid receptor transcripts in two human leukemic cell lines. Biochemistry, 2003,42:10978-10990.
21. Breslin MB, Geng CD, Vedeckis WV. Multiple promoters existin the human GR gene, one of which is activated by glucocorticoids. Mol Endocrinol, 2001,15:1381-1395.
22. Presul E, Schmidt S, Kofler R, et al. Identification, tissueexpression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. J Mol Endocrinol, 2007,38:79-90.
23. Eisen LP, Elsasser MS, Harmon JM. Positive regulation of theglucocorticoid receptor in human T-cells sensitive to the cytolytic effects of glucocorticoids. J Biol Chem, 1988,263: 12044-12048.
24. Geng CD, Vedeckis WV. A new lineage specificautoupregulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells. Mol Endocrinol, 2011,25: 44-57
25. Schwartz JR, Sarvaiya PJ, Vedeckis WV. Glucocorticoidreceptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia. Mol Cell Endocrinol, 2010,320: 76-86.
26. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet, 2008,371:1030-1043.
27. Carroll WL, Bhojwani D, Min DJ, et al. Pediatric acutelymphoblastic leukemia. Hematology Am Soc Hematol Educ Program, 2003,2003:102-131.
28. Ramdas J, Liu W, Harmon JM. Glucocorticoid-induced celldeath requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. Cancer Res, 1999,59: 1378-1385.
29. Gruber G, Carlet M, Turtscher E, et al. Levels of glucocorticoidreceptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis. Leukemia, 2009,23: 820-823.
30. Tissing WJ, Lauten M, Meijerink JP, et al. Expression of theglucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia. Haematologica, 2005,90:1279-1281.
31. Tissing WJ, Meijerink JP, Brinkhof B, et al. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL. Blood, 2006,108:1045-1049.
32. Schwartz CL, Thompson EB, Gelber RD, et al. Improvedresponse with higher corticosteroid dose in children with acute lymphoblastic leukemia. J Clin Oncol, 2001,19:1040-1046.
33. Hillmann AG, Ramdas J, Multanen K, et al. Glucocorticoidreceptor gene mutations in leukemic cells acquired in vitro and in vivo. Cancer Res, 2000,60:2056-2062.
34. Powers JH, Hillmann AG, Tang DC, et al. Cloning andexpression of mutant glucocorticoid receptors from glucocorticoid-sensitive and-resistant human leukemic cells. Cancer Res, 1993,53:4059-4065.
35. Ashraf J, Thompson EB. Identification of the activation-labilegene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Mol Endocrinol, 1993,7:631-642.